Midterm pp
問題一覧
1
Botulinum toxin
2
Reuptake mechanism
3
Inhibit the release of NE from AP dependent vesicles
4
Cholinesterase does not degrade it
5
Carbachol causes bradycardia
6
Carbachol increases secretions
7
Carbachol
8
Lobeline
9
Pilocarpine
10
Alkyl phosphates
11
Hypertension
12
Myasthenia gravis
13
Rivastigmine
14
It is metabolized by Achesterase
15
Neostigmine
16
Succinylcholine
17
Neostigmine enhances peristalsis in the gut
18
Edrophonium is a reversible inhibitor with a short dissociation constant
19
Rivastigmine
20
it is metabolized by Achesterase
21
useful in treatment of Parkinson
22
Solifenacin
23
Ipratropium
24
bradycardia
25
NE not cause high frequency tachycardia
26
Procyclidine
27
Causes tachycardia
28
Atropine irritates CNS
29
Myosis
30
8-10 days
31
atropine
32
its mydriatic effect lasts 2-3 hours long
33
motion sickness
34
Ephedrine
35
Dobutamine
36
Adrenaline has a bronchoconstriction effect
37
Dobutamine
38
has a short half life
39
Relaxes the uterine muscle
40
Isoprenaline
41
Phenylephrine can be used for rhinitis
42
Ephedrine
43
Ephedrine
44
Phenylephrine
45
Preganancy HT
46
Clondine
47
Carvedilol
48
Carvedilol
49
It reduces BP
50
Prazosin
51
May cause tachycardia
52
Urapidil
53
Phentolamine
54
Tamsulosin
55
Bradycardia
56
Propranolol
57
Treatment of hyperthyroidism
58
The need to do a slow dose reduction
59
Asthma bronchiale
60
tremor
61
hypokalemia
62
cisatracurium
63
Tubocurarine
64
use of Achesterase inhibitors
65
GABA-B receptor agonism
66
Pipecuronium
67
Baclofen binds to a GPCR
68
Neostigmine
69
Dantrolene inhibits the ryanodine R
70
NMDA
71
Cell nuclear R
72
receptor up regulation enhances its maximal effect
73
The competitive antagonist is the agonist that shifts dose-response curve to the left
74
Partial agonist
75
They have no therapeutic significance
76
It gets pushed to the right
77
It reduces the maximal effect of an agonist acting on the same receptor
78
The intrinsic efficacy of a partial agonist is higher than zero
79
The equilibrium between the sides of a membrane is determined by the full concentration of the drug
80
If the potency is higher the efficacy is higher as well
81
It can ce caused when the drug does not bind to the sufficient number of R required to the therapeutic effect
82
oral
83
The mechanism greatly reduces the bioavailability of drugs
84
Excretion
85
The abosorption of a drug is linear if doubling the dose doubles the absorbed amount
86
Amino acids cannot cross BBB
87
Are ABC transporters obtaining energy using electrochemical potential difference
88
Urine
89
oral
90
glucuronidation
91
ATP
92
Elimination is faster at higher plasma concentrations
93
The metabolism of the compound is independent of plasma concentration
94
in case of zero order kinetics elimination speed does not depend on plasma concentration
95
it linearly related to volume of distribution
96
Cyclopentolate
97
Ipratropium
98
Fenoterol is typically applied topically
99
sedation
Week3-4
Week3-4
n · 57問 · 2年前Week3-4
Week3-4
57問 • 2年前Weekly2
Weekly2
n · 65問 · 2年前Weekly2
Weekly2
65問 • 2年前Weekly2-2
Weekly2-2
n · 34問 · 2年前Weekly2-2
Weekly2-2
34問 • 2年前Weekly2-3
Weekly2-3
n · 10問 · 2年前Weekly2-3
Weekly2-3
10問 • 2年前Weekly3
Weekly3
n · 40問 · 2年前Weekly3
Weekly3
40問 • 2年前Weekly3-2
Weekly3-2
n · 33問 · 2年前Weekly3-2
Weekly3-2
33問 • 2年前Weekly3-3
Weekly3-3
n · 47問 · 2年前Weekly3-3
Weekly3-3
47問 • 2年前Weekly3-4 Viscerosensory
Weekly3-4 Viscerosensory
n · 34問 · 2年前Weekly3-4 Viscerosensory
Weekly3-4 Viscerosensory
34問 • 2年前Week6-skeletal muscle
Week6-skeletal muscle
n · 10問 · 2年前Week6-skeletal muscle
Week6-skeletal muscle
10問 • 2年前Week6- Heart
Week6- Heart
n · 37問 · 2年前Week6- Heart
Week6- Heart
37問 • 2年前Weekly4-1
Weekly4-1
n · 95問 · 2年前Weekly4-1
Weekly4-1
95問 • 2年前Week9
Week9
n · 27問 · 2年前Week9
Week9
27問 • 2年前⭐️Parameters
⭐️Parameters
n · 64問 · 2年前⭐️Parameters
⭐️Parameters
64問 • 2年前DNA
DNA
n · 54問 · 2年前DNA
DNA
54問 • 2年前RNA
RNA
n · 14問 · 2年前RNA
RNA
14問 • 2年前Week11
Week11
n · 23問 · 2年前Week11
Week11
23問 • 2年前Week12
Week12
n · 23問 · 2年前Week12
Week12
23問 • 2年前Week13
Week13
n · 21問 · 2年前Week13
Week13
21問 • 2年前week1
week1
n · 32問 · 2年前week1
week1
32問 • 2年前genetics quiz
genetics quiz
n · 30問 · 2年前genetics quiz
genetics quiz
30問 • 2年前genetics mcq
genetics mcq
n · 49問 · 2年前genetics mcq
genetics mcq
49問 • 2年前genetics2
genetics2
n · 86問 · 2年前genetics2
genetics2
86問 • 2年前Week2
Week2
n · 8問 · 2年前Week2
Week2
8問 • 2年前Immunology final
Immunology final
n · 99問 · 2年前Immunology final
Immunology final
99問 • 2年前Week3
Week3
n · 17問 · 2年前Week3
Week3
17問 • 2年前Week3-4 Thyroid
Week3-4 Thyroid
n · 20問 · 1年前Week3-4 Thyroid
Week3-4 Thyroid
20問 • 1年前general
general
n · 56問 · 1年前general
general
56問 • 1年前general2
general2
n · 81問 · 1年前general2
general2
81問 • 1年前Week4-body
Week4-body
n · 10問 · 1年前Week4-body
Week4-body
10問 • 1年前Week4-Caicium, bone
Week4-Caicium, bone
n · 20問 · 1年前Week4-Caicium, bone
Week4-Caicium, bone
20問 • 1年前Week5,6-sexual
Week5,6-sexual
n · 23問 · 1年前Week5,6-sexual
Week5,6-sexual
23問 • 1年前immunology
immunology
n · 55問 · 1年前immunology
immunology
55問 • 1年前3
3
n · 94問 · 1年前3
3
94問 • 1年前Internal Metabolism
Internal Metabolism
n · 28問 · 1年前Internal Metabolism
Internal Metabolism
28問 • 1年前cell cycle
cell cycle
n · 9問 · 1年前cell cycle
cell cycle
9問 • 1年前mid1?
mid1?
n · 5問 · 1年前mid1?
mid1?
5問 • 1年前mid2
mid2
n · 41問 · 1年前mid2
mid2
41問 • 1年前Week8
Week8
n · 12問 · 1年前Week8
Week8
12問 • 1年前sensory
sensory
n · 35問 · 1年前sensory
sensory
35問 • 1年前nerve
nerve
n · 15問 · 1年前nerve
nerve
15問 • 1年前genetic3
genetic3
n · 85問 · 1年前genetic3
genetic3
85問 • 1年前gene4
gene4
n · 19問 · 1年前gene4
gene4
19問 • 1年前Week12
Week12
n · 13問 · 1年前Week12
Week12
13問 • 1年前Week13
Week13
n · 18問 · 1年前Week13
Week13
18問 • 1年前week11
week11
n · 15問 · 1年前week11
week11
15問 • 1年前1
1
n · 75問 · 1年前1
1
75問 • 1年前Midterm1-2
Midterm1-2
n · 66問 · 1年前Midterm1-2
Midterm1-2
66問 • 1年前1
1
n · 92問 · 1年前1
1
92問 • 1年前2
2
n · 25問 · 1年前2
2
25問 • 1年前Mid2-1
Mid2-1
n · 99問 · 1年前Mid2-1
Mid2-1
99問 • 1年前Minimum-mycology
Minimum-mycology
n · 27問 · 1年前Minimum-mycology
Minimum-mycology
27問 • 1年前Minimum-virology
Minimum-virology
n · 49問 · 1年前Minimum-virology
Minimum-virology
49問 • 1年前Minimum-general
Minimum-general
n · 66問 · 1年前Minimum-general
Minimum-general
66問 • 1年前Minimum-systemic
Minimum-systemic
n · 99問 · 1年前Minimum-systemic
Minimum-systemic
99問 • 1年前Mid2-2
Mid2-2
n · 99問 · 1年前Mid2-2
Mid2-2
99問 • 1年前Mod2-3
Mod2-3
n · 17問 · 1年前Mod2-3
Mod2-3
17問 • 1年前Minimum-systemic2
Minimum-systemic2
n · 63問 · 1年前Minimum-systemic2
Minimum-systemic2
63問 • 1年前Minimum-parasitology
Minimum-parasitology
n · 77問 · 1年前Minimum-parasitology
Minimum-parasitology
77問 • 1年前問題一覧
1
Botulinum toxin
2
Reuptake mechanism
3
Inhibit the release of NE from AP dependent vesicles
4
Cholinesterase does not degrade it
5
Carbachol causes bradycardia
6
Carbachol increases secretions
7
Carbachol
8
Lobeline
9
Pilocarpine
10
Alkyl phosphates
11
Hypertension
12
Myasthenia gravis
13
Rivastigmine
14
It is metabolized by Achesterase
15
Neostigmine
16
Succinylcholine
17
Neostigmine enhances peristalsis in the gut
18
Edrophonium is a reversible inhibitor with a short dissociation constant
19
Rivastigmine
20
it is metabolized by Achesterase
21
useful in treatment of Parkinson
22
Solifenacin
23
Ipratropium
24
bradycardia
25
NE not cause high frequency tachycardia
26
Procyclidine
27
Causes tachycardia
28
Atropine irritates CNS
29
Myosis
30
8-10 days
31
atropine
32
its mydriatic effect lasts 2-3 hours long
33
motion sickness
34
Ephedrine
35
Dobutamine
36
Adrenaline has a bronchoconstriction effect
37
Dobutamine
38
has a short half life
39
Relaxes the uterine muscle
40
Isoprenaline
41
Phenylephrine can be used for rhinitis
42
Ephedrine
43
Ephedrine
44
Phenylephrine
45
Preganancy HT
46
Clondine
47
Carvedilol
48
Carvedilol
49
It reduces BP
50
Prazosin
51
May cause tachycardia
52
Urapidil
53
Phentolamine
54
Tamsulosin
55
Bradycardia
56
Propranolol
57
Treatment of hyperthyroidism
58
The need to do a slow dose reduction
59
Asthma bronchiale
60
tremor
61
hypokalemia
62
cisatracurium
63
Tubocurarine
64
use of Achesterase inhibitors
65
GABA-B receptor agonism
66
Pipecuronium
67
Baclofen binds to a GPCR
68
Neostigmine
69
Dantrolene inhibits the ryanodine R
70
NMDA
71
Cell nuclear R
72
receptor up regulation enhances its maximal effect
73
The competitive antagonist is the agonist that shifts dose-response curve to the left
74
Partial agonist
75
They have no therapeutic significance
76
It gets pushed to the right
77
It reduces the maximal effect of an agonist acting on the same receptor
78
The intrinsic efficacy of a partial agonist is higher than zero
79
The equilibrium between the sides of a membrane is determined by the full concentration of the drug
80
If the potency is higher the efficacy is higher as well
81
It can ce caused when the drug does not bind to the sufficient number of R required to the therapeutic effect
82
oral
83
The mechanism greatly reduces the bioavailability of drugs
84
Excretion
85
The abosorption of a drug is linear if doubling the dose doubles the absorbed amount
86
Amino acids cannot cross BBB
87
Are ABC transporters obtaining energy using electrochemical potential difference
88
Urine
89
oral
90
glucuronidation
91
ATP
92
Elimination is faster at higher plasma concentrations
93
The metabolism of the compound is independent of plasma concentration
94
in case of zero order kinetics elimination speed does not depend on plasma concentration
95
it linearly related to volume of distribution
96
Cyclopentolate
97
Ipratropium
98
Fenoterol is typically applied topically
99
sedation